The Leukemia Therapeutics Treatment Market is projected to expand at a 7.1% CAGR from 2022 to 2032. In terms of income, North America commands the market for leukaemia therapeutic therapies.Leukaemia is characterised as a malignancy that is found in our body’s white blood cells (WBC). Our body uses white blood cells.
/PRNewswire/ The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around.
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today it has ended its AKS-452 licensing, manufacturing, and commercialization agreement with Stelis Biopharma Limited, an arm of Strides Pharma Science Ltd.